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Abstract
Background: Foot ulcers are a significant problem for people with diabetes. Comprehensive
assessments of risk factors associated with diabetic foot ulcer are recommended in clinical
guidelines to decrease complications such as prolonged healing, gangrene and amputations, and to
promote effective management. However, the translation of clinical guidelines into nursing practice
remains fragmented and inconsistent, and a recent homecare chart audit showed less than half the
recommended risk factors for diabetic foot ulcers were assessed, and peripheral neuropathy (the
most significant predictor of complications) was not assessed at all.
Strong leadership is consistently described as significant to successfully transfer guidelines into
practice. Limited research exists however regarding which leadership behaviours facilitate and
support implementation in nursing.
The purpose of this pilot study is to evaluate the impact of a leadership intervention in community
nursing on implementing recommendations from a clinical guideline on the nursing assessment and
management of diabetic foot ulcers.
Methods:  Two phase mixed methods design is proposed (ISRCTN 12345678). Phase I:
Descriptive qualitative to understand barriers to implementing the guideline recommendations, and
to inform the intervention. Phase II: Matched pair cluster randomized controlled trial (n = 4
centers) will evaluate differences in outcomes between two implementation strategies. Primary
outcome: Nursing assessments of client risk factors, a composite score of 8 items based on
Diabetes/Foot Ulcer guideline recommendations.
Intervention: In addition to the organization's 'usual' implementation strategy, a 12 week leadership
strategy will be offered to managerial and clinical leaders consisting of: a) printed materials, b) one
day interactive workshop to develop a leadership action plan tailored to barriers to support
implementation; c) three post-workshop teleconferences.
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Discussion: This study will provide vital information on which leadership strategies are well
received to facilitate and support guideline implementation. The anticipated outcomes will provide
information to assist with effective management of foot ulcers for people with diabetes.
By tracking clinical outcomes associated with guideline implementation, health care administrators
will be better informed to influence organizational and policy decision-making to support evidence-
based quality care. Findings will be useful to inform the design of future multi-centered trials on
various clinical topics to enhance knowledge translation for positive outcomes.
Trial Registration: Current Control Trials ISRCTN06910890
Background: diabetic foot ulcers
Diabetes mellitus, a complex, life-long metabolic disorder
characterized by raised blood glucose concentrations,
affects 4.2 percent of the world's population and over 1.5
million Canadians [1,2]. Ulceration of the foot is a signif-
icant problem for people with diabetes, affecting 15 per-
cent at some time in their life [3,4]. Foot complications
are a major reason for hospital admissions, accounting for
approximately 20 percent of all diabetes-related admis-
sions in North America [1]. Foot ulcers precede 85 percent
of lower limb amputations [4,5] and 30 percent of those
undergoing amputation die within the following year [6].
Diabetes pathology that increases risk of foot ulcerations
and complications includes peripheral neuropathy
(impairment of nerve function), peripheral vascular dis-
ease, limited joint mobility and deformity [1,4,5,7]. The
triad of neuropathy, deformity, and trauma is present in
almost two thirds of people with foot ulcers [5] with foot-
wear being a major cause of traumatic ulcers [8].
Lack of awareness of risk factors associated with diabetic
foot ulcer by health care professionals and patients adds
to unnecessary morbidity such as prolonged healing,
infections and gangrene that may result in amputations
[4,5,9]. Mills et al. (1991) reviewed records of 55 diabetic
patients with localized gangrene or infection on a vascular
surgical unit and found 29 percent were delayed in referral
for definitive care due to a lack of recognition by practi-
tioners of ischemia or an underestimation of the severity
of infections [10].
Comprehensive assessments by health care professionals
of risk factors are recommended in clinical practice guide-
lines for effective management and treatment of diabetic
foot ulcers, and are supported by strong empirical evi-
dence [1,4-7,11-16]. A recent Cochrane review showed
managing ulcers with hydrogel dressings when compared
to usual care (gauze dressings) improved healing rates by
23 percent at 12 to 20 weeks (95% CI 10–36%) [7].
Assessments are recommended to include: peripheral
neuropathy, vascular status, structural deformities, infec-
tion and ulcer size [1,5,9,12-15]. Referrals to multidisci-
plinary foot care specialists [5,12,13] and patient
education [4,17] are equally emphasized.
Problem: Implementing clinical guideline 
recommendations
Clinical practice guidelines synthesize and translate high
quality research evidence into recommendations for prac-
tice, and provide an easy and accessible tool for bridging
the evidence-practice gap [18-21]. For practice change to
occur however, guidelines must be utilized, and their
timely and effective transfer into clinical practice remains
fragmented and inconsistent [21-24]. Implementation
strategies directed at individuals, the environment and the
organizational context are necessary for successful imple-
mentation and practice change to occur [20,25-27]. In
recent Cochrane reviews, tailored interventions that focus
on individual and organizational barriers to change
showed promise for implementing change and improving
patient care [28], and interactive workshops were found
to have moderately large effects on changing professional
practice [29].
The importance of top managers' involvement and com-
mitment in implementing innovations such as guidelines
and change have been emphasized outside [30-39] and
within healthcare settings [40-45]. Descriptive and quali-
tative evidence has identified leadership and management
behaviours as having an important impact on nurses'
work environments [42,46-50] and their use of research
evidence to inform practice [27,51-63]. Similarly, a sys-
tematic review of 30 studies identified the lack of support
from managers, and 'other staff' to be one of the greatest
barriers to nurses' use of research [60]. Management
behaviours such as support and commitment [56,58,64-
69], policy revisions [66,70] and monitoring of clinical
outcomes [66,71] have been described as enablers to
nurses' use of research [72]. Limited experimental
research exists however regarding which behaviours are
most effective to facilitate guideline implementation in
nursing. A recent mixed methods study of 37 organiza-
tions found leadership to be the only predictor of sus-
tained use of clinical guideline recommendations two andImplementation Science 2008, 3:51 http://www.implementationscience.com/content/3/1/51
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three years post-implementation, accounting for 47 per-
cent of the variance (p < .001) [73]. Using grounded the-
ory to analyze 9 of the 37 organizations, Gifford et al.
found patterns of leadership and managerial behaviours
in organizations that sustained practice change based on
guideline recommendations (n = 4) at 2 and 3 years dif-
fered when compared to organizations that did not sus-
tain practice change (n = 5) [63]. A conceptual model was
developed from the analysis that operationalizes leader-
ship behaviours for implementing and sustaining practice
change.
Study Aim
The aim of this pilot study is to evaluate the impact of a
leadership intervention on implementing new recom-
mendations from a clinical practice guideline on nursing
assessments and management of foot ulcers for people
with diabetes in community nursing practice. Specific
objectives include:
1) To identify barriers and develop a tailored leadership
intervention for home care nurse managers, supervisors,
resource nurses and clinical staff to influence implemen-
tation of selected recommendations from the Registered
Nurses Association of Ontario (RNAO) clinical practice
guideline for care of foot ulcers for people with diabetes.
2) To determine the impact of the intervention on client,
nurse and system outcomes.
3) To understand the feasibility of influencing leadership
behaviours through the intervention.
4) To test and refine a model of leadership for implement-
ing practice change.
We plan to test the following study hypotheses:
H1: Nurses working in centers that receive the intervention
will obtain significantly higher scores for practicing in
accordance with guideline recommendations than control
group.
H0: No change in group means will occur following the
intervention.
Design/Methods
A two phase mixed method design is proposed (Figure 1).
A pilot study is planned because there is little information
regarding effective leadership behaviours for implement-
ing practice change in nursing, and there is a need to test
the intervention strategies prior to launching a larger
multi-centered trial. Phase one involves descriptive quali-
tative methods to understand barriers to implementing
the guideline recommendations and to refine the inter-
vention strategy to be useful and appealing to leaders. A
cluster randomized controlled trial, considered the opti-
mal design when evaluating strategies to change profes-
sional behaviour [20,74], will evaluate differences in
outcomes between the two implementation strategies.
Randomization will occur at the unit level to minimize
threats of experimental contamination [20,75,76].
Site
The research is being conducted in a home and commu-
nity health-care service organization that provides nursing
care through 23 centers in the province of Ontario Can-
ada. The organization employs approximately 1500 nurs-
ing staff, 65 managers and supervisors, and 20 clinical
resource nurses, and 7 clinical directors. Approximately
30 to 40 percent of clients receiving nursing services are
diabetic, and clinical directors identified foot care for this
population as a priority clinical topic, with a notable gap
between current practices and guideline recommenda-
tions. For example no clients are currently being assessed
for peripheral neuropathy the most significant predictor
of ulcers, and recent chart audits indicated that co-mor-
bidity, vascular status and wound size were not docu-
mented in at least 50 percent of charts for foot and leg
ulcers. The organization has previously implemented clin-
ical practice guidelines at an estimated cost of $60,000 per
implementation. To date implementation strategies have
had mixed success. Implementation of the RNAO guide-
line Assessing and Managing Foot Ulcers for People with Dia-
betes [13] is planned in 2008.
Primary outcome
Nursing assessments of client risk factors scores (NACRF),
a composite score of 8 items based on recommendations
from the Diabetes/Foot Ulcer guideline. The 8 items were
chosen in consultation with clinical experts in diabetes
and wound management, have a high level of research
evidence for prediction of poor outcomes [13], and were
reviewed for content validity by researchers and clinical
experts in the field. Four of the eight items were previously
used in a chart audit evaluation of another RNAO guide-
line related to the prevention of foot complications in
people with diabetes [77,78].
Secondary outcomes
1) proportion of people with healed ulcers at 12 weeks
(defined as complete wound closure),
2) healing times in number of weeks,
3) types of treatments used (eg: hydrogel dressings, sharp
debridement, offloading devices),
4) referral rates to specialists services,
5) documented patient education,Implementation Science 2008, 3:51 http://www.implementationscience.com/content/3/1/51
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6) proportion clients assessed for all items in the NACRF
scale (all-or-none measure) [79],
7) Nursing participant satisfaction and perceived utility of
elements of the intervention.
Sample
All centers (approximately 10) with the minimum
number of clients being treated for diabetic foot ulcers to
satisfy sample size calculations will be invited to partici-
pate in the study. Two centers will be randomly assigned
to participate in phase one and four will be randomly
assigned for phase two. The four sites in phase two will be
randomly allocated to control (n = 2) or experimental (n
= 2) groups.
Sample size
Sample size calculations were determined, and are based
on the use of an independent t-test on NACRF scores at
the end of the study. The following assumptions have
been made: alpha = .0.05 (two-tailed), Beta = 0.20 and an
expected change in NACRF scores of 20 percent. Although
all items within the NACRF have not been previously
used, four were previously evaluated in a pre/post chart
audit that showed a 26 percent absolute improvement in
nursing documentation (range -3.6 to 57.1) [78]. Thus, an
estimate of 20 percent improvement will be used. In addi-
tion, standard deviations (SD) and intra-cluster correla-
tion coefficients (ICCs = ρ) for NACRF are presently
unknown. It is however, estimated that the effect size may
be as small as 1.00 but to be conservative 0.83 (SD = 3) is
assumed for this calculation. Based on these assumptions,
30 charts will be needed in both intervention and control
groups (n = 60). While it is not known exactly how many
clients with diabetes will be on service for foot ulcers dur-
ing the study period, senior administrators have reassured
investigators that a minimum of 30 clients per group is
feasible.
Power estimates for secondary outcomes
The anticipated rate of healing in the control group is 24
percent in 12 weeks [16]. For the proportion of ulcers
Design: Two phased mixed methods pilot study Figure 1
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healed and healing times, 30 charts in control and inter-
vention groups would yield 80 percent power to detect an
absolute increase in healing rates of 40 percent (alpha .05,
two tailed). The study is also powered to detect an abso-
lute increase of 40 percent in referral rates and patient
education, also measured as a proportion.
Data Collection
Baseline
All adult clients (18 years or older) diagnosed with Type 1
or Type 2 diabetes being treated for a first or recurring foot
ulcer(s) will be eligible for the study. Using data abstrac-
tion forms modified from a previous guideline evaluation
project [77], chart audits will be performed at control and
experimental sites prior to randomization until sample
size is achieved or up to 12 weeks prior to the interven-
tion. Chart audit data collectors will be trained and super-
vised by researchers with experience in conducting chart
audits. Interrater and test-retest reliability will be assessed
in a random review of 10 percent of charts.
PHASE I: Barriers Assessment and Intervention 
Development
Semi-structured interviews will be conducted at two cent-
ers with a sample of managers, supervisors, resource
nurses and 2 'preceptor' staff nurses from each site (n =
10). Preceptor staff are experienced clinical nurses who
volunteer to provide support to novice or newly hired
nurses regarding clinical issues. The interview guide is
based on previously published guides for assessing barri-
ers and supports [80], and has been structured to under-
stand components of an intervention strategy considered
useful to managers and clinical leaders. Results of phase I
will inform content and structure of the intervention strat-
egy.
PHASE II: Intervention Strategy
Control Group
Staff at each center will receive the 'usual' guideline imple-
mentation strategy consisting of: 1) a formal guideline
launch; 2) self-directed learning package, 3) educational
sessions for staff related to the clinical application of prac-
tice recommendations. Senior administrators estimated
that approximately 70 percent of staff typically attend
'usual' strategies.
Experimental Group
In addition to the 'usual' implementation strategy, a 12
week leadership strategy will be offered to mangers, super-
visors, resource nurses, and 2 preceptor staff from each
center to facilitate and support implementation, consist-
ing of:
1) Mailed package of printed materials: to include study
purpose; summary of recommendations, models of lead-
ership and planned change; literature article; three ques-
tions to assess barriers to nurses assessing and managing
foot ulcers in accordance to the guideline recommenda-
tions. Review time: approx 15–30 minutes.
2) Interactive workshop (one day): Content and activities
will be tailored to results of phase one, planned to
include: a) evidence and theory on leadership and imple-
menting practice change; b) focus group discussions
about barriers to implementing the recommendations; c)
role playing exercises; and d) facilitated development of a
team leadership implementation plan for each center, tai-
lored to identified barriers.
3) Post-workshop teleconferences: (2, 6, and 10 weeks
after workshop) to provide a forum for questions, discus-
sions and networking amongst participants.
Guiding Theoretical Framework
The theoretical underpinnings of the proposed interven-
tion are based on mechanisms of planned change as
described in the Ottawa Model of Research Use (OMRU©)
[52,81], effective leadership behaviours described by Yukl
[82], and leadership for guideline implementation
described by Gifford et al [63].
The OMRU is a planned change framework for knowledge
transfer in health care delivery [52]. Derived from evi-
dence and theories of change, the OMRU recognizes that
practice change is not a linear process, but involves simul-
taneous and interactive relationships between the nature
of the innovation, the potential adopters, and the context
within the practice environment. Three key processes
involved are: 1) assessing barriers and supports; 2) devel-
oping and monitoring interventions tailored to barriers
and supports; 3) evaluating outcomes. The underlying
mechanism is that tailoring intervention strategies to
address barriers and strengthen supports related to the
innovation, potential adopters and practice environment
will result in practice change.
The OMRU provides a template to assess barriers and sup-
ports for implementing change and will facilitate the
selection of intervention strategies with the best probabil-
ity of success. The relevance and pragmatic utility of the
OMRU for guiding implementation of innovations
(including nursing guidelines) has been demonstrated in
previous research [83-87].
Leadership is "the process of influencing others to under-
stand and agree about what needs to be done and how to
do it, and the process of facilitating individual and collec-
tive efforts to accomplish shared objectives" [[82], p.8].
Three meta-categories of effective leadership behaviours
described by Yukl and supported by decades of researchImplementation Science 2008, 3:51 http://www.implementationscience.com/content/3/1/51
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[82,82,88,89], provide the foundation for this study: 1)
relations-orientated, 2) change-orientated and 3) task-ori-
entated. Relations-oriented behaviours include support-
ing, developing personal skills and job adjustments, and
recognizing others and their contributions. Relations-ori-
ented behaviours increase mutual trust, cooperation
among members, and commitment to a unit and organi-
zation. Change-oriented behaviours are concerned with
integrating a vision, developing strategies and building
coalitions to support change, creating a sense of need and
demonstrating commitment to change. Task-oriented
behaviours include clarifying roles, monitoring opera-
tions and performance, and the efficient use of resources
[82].
Three leadership themes emerged as central to imple-
menting guidelines in the grounded theory study by Gif-
ford et al., and these align closely with Yukl's [82]
metacategories of effective leadership behaviours. Leaders
were found to have: 1) facilitated staff through relations-
oriented behaviours (e.g.: support, encouragement and
recognition); 2) created a positive milieu within the clini-
cal practice environment through change-related behav-
iours (e.g.: reinforced goals and philosophies of care); and
3) influenced organizational structures and processes
through task-oriented behaviours (e.g.: providing
resources, policies and monitoring). Together these
behaviours influenced individuals, practice environments
and infrastructures to enable nurses to practice based on
guideline recommendations.
Drawing on the work of Van de Ven et al. (1999), effective
leadership at different hierarchical levels is necessary for
the adoption of new innovations in organizations [90].
Successful implementation in healthcare is dependent on
strong effective leadership to create a context which is
receptive to change [26,27,51,63,82,90-96]. The organiza-
tional context exerts a particularly powerful set of influ-
ences on nurses' adoption of new innovations [81,97,98].
Extensive managerial involvement, commitment and atti-
tude toward change, role clarity, and leadership styles are
significantly associated with maintaining the momentum
of innovation adoption in organizations
[32,33,90,99,100]. A 'road map" that explains what lead-
ers do is not however possible due to the inherent unpre-
dictability and nonlinear processes of innovation
adoption [90]. "Management cannot ensure innovation
success but can influence its odds" (p.11, 88). Leadership
is an integral part of managerial roles, and is necessary for
managers to influence change [34,82,96,101-104]. Indi-
viduals and organizational context must be influenced for
practice change to occur based on new innovations [20].
The proposed intervention aims to influence individuals,
the practice environment and organizational context
through leadership processes and behaviours that manage
barriers and enable practice change to occur. (Figure 2)
Post-intervention measures
Chart audits will be conducted on all patients being
treated for diabetic foot ulcers up to 12 weeks following
the intervention. To understand the leadership and man-
agement behaviours that influenced nursing practice,
semi structured qualitative interviews will be conducted
with managers, supervisors and resource nurses and staff
nurses at control and experimental sites (n = 20). The
experimental group interview guide will also ask for par-
ticipants' opinions regarding the usefulness of the inter-
vention. The interview guides are based on previously
published guides for assessing barriers and supports [80],
and previous research on implementing guidelines [105].
To evaluate satisfaction and perceived utility of the one
day workshop, an evaluation form, based on previously
evaluations from RNAO guideline implementations,
[106] will be administered at the end of the workshop.
Data Analysis
Pre/post univariate descriptive data will be computed for
demographics of patients and staff.
Primary Outcome: Composite NACRF scores
Eeach item within the scale will be coded dichotomously
(1 = yes; 0 = no), and a total score calculated out of 8.
Bivariate analysis using independent groups t-tests will be
conducted to assess the significance of differences pre/
post intervention between control and experimental
groups. The alpha level will be pre-set at .05, and 95 per-
cent confidence intervals calculated. An 'intent to treat'
analysis will be used [75].
Secondary Outcomes
The proportion of people with healed ulcer(s) at 12
weeks, and time to complete healing will be calculated.
Types of treatments used (eg: hydrogel dressings, sharp
debridement, offloading devices) will be calculated. Cli-
ents with documented patient education and referrals will
be dichotomously coded (1 = yes; 0 = no/don't know).
Independent groups t-tests for continuous variables, and
chi squares for categorical variables will determine differ-
ences before and after the intervention within each center,
and between control and experimental groups. Descrip-
tive statistics will be used to evaluate nursing participants'
satisfaction and perceived utility with the elements of the
intervention.
Other Outcomes
ICCs (ρ) will be calculated on pre/post measures of com-
posite NACRF scores, and demographic characteristics of
clients (e.g.: age, gender) [107]. Matching is expected to
minimize between-unit variations, and previous researchImplementation Science 2008, 3:51 http://www.implementationscience.com/content/3/1/51
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shows ICCs for the process of care to be high [20,74,108].
ICCs from this study will be useful to inform future stud-
ies regarding sample size calculations [107,109,110].
Qualitative Findings
To understand how the intervention influenced leader-
ship practices, data from qualitative interviews will be
audio-taped, transcribed, entered into qualitative software
(NVIVO) and analyzed using content analysis techniques
involving an iterative process of data reduction, data dis-
play, conclusion drawing and verification [111].
Discussion
Limitations
An inherent limitation of collecting data through chart
audit is the documented data obtained may potentially
underestimate actual care [112]. Other methods of data
collection, such as direct observations are not feasible for
this pilot study due to geographical distances and associ-
ated costs of observing home-care nurses provide care in
patients' homes throughout the province. A second limi-
tation of collecting data through chart audits involves
reviewers accuracy, impartiality, attentiveness and consist-
ency in extracting data [112]. Having an experienced
research manager overseeing the process, and pilot testing
for interrater and test-retest reliability will assist with
addressing this limitation. Additionally, this is a pilot
study and not sufficiently powered to account for the
effect of clustering.
Ethical Considerations
Prior to commencement, ethical approval will be
obtained from University of Ottawa Research Ethics Board
which follows Tri-council guidelines [113]. Details of eth-
ical considerations, including informed consent, ano-
nymity and confidentiality are found in ethics submission
Conceptual Framework Figure 2
Conceptual Framework.
Relations-Orientated 
Behaviours
 Supports
 Develops
 Recognizes
Facilitates Individual    
Staff
 Supports & encourages
 Accessible & visible
 Communicates well
Change-Orientated 
Behaviours
 Influences culture
 Develops vision
 Implements change
Creates Milieu of Best 
Practices
 Reinforces goals / vision
 Influences change
 Role models commitment
Shapes  Structure & 
Process
 Provides resources, policy, 
training & education  
 Monitors operations
Individuals                      Practice Environment/Work Culture                      Infrastructure
Positive Outcomes
Patients        Staff              Organization/System
EFFECTIVE LEADERSHIP (Yukl, 2006)
LEADERSHIP FOR IMPLEMENTING GUIDELINES (Gifford et al, 2006)
manage barriers & enable guideline-informed care
Figure 2:  Conceptual Framework
Task-Orientated  
Behaviours
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 Monitors 
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form. Briefly, a numerical coding system will be used to
track individual participant and chart audit data. Names
of interview participants will be kept separated from data
collection forms and locked at the University of Ottawa
Nursing Best Practice Research Unit. Names from chart
audits will be kept by the research manager at the partici-
pating organization in a secured place; only numerically
coded data will be sent to investigators. Only aggregated
data will be reported. Information consent forms will be
available in English and French. Data will be securely
stored for 5 years after study conclusion (e.g. December,
2014).
Feasibility
This study aligns with the participating organization's
timeline to implement the Diabetes/Foot Ulcer BPG, and
has been developed in consultations with senior adminis-
trators to ensure feasibility, support, and compatibility
with organizational direction, initiatives and training
strategies.
Potential Impact on Nursing Care
This pilot study will contribute to the development of
leadership strategies to facilitate implementation of
guideline recommendations on a priority clinical topic in
community nursing. The anticipated outcome is informa-
tion to assist with more effective management and faster
healing of foot ulcers in community health nursing for
people with diabetes. With the high cost of guideline
implementation, this study will provide vital information
on which strategies are well received when implementing
practice change. By tracking clinical outcomes associated
with guideline use, nursing administrators will be better
informed to influence organizational and policy decisions
to support high quality nursing care. Findings will be use-
ful to inform the design of future multi-centered trials on
various clinical topics, and to enhance the science of
knowledge translation for evidence-informed practice
change that impacts quality nursing care and client out-
comes.
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